相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting Angiogenesis in Biliary Tract Cancers: An Open Option
Valeria Simone et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Progression-free survival of up to 8 months of an advanced intrahepatic cholangiocarcinoma patient treated with apatinib: a case report
Fu-Chao Ma et al.
ONCOTARGETS AND THERAPY (2017)
The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma
Rachna T. Shroff et al.
BRITISH JOURNAL OF CANCER (2017)
VEGFR2 inhibition by RNA interference affects cell proliferation, migration, invasion, and response to radiation in Calu-1 cells
Y. Liu et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2016)
Insulin-Like Growth Factor-1 and Vascular Endothelial Growth Factor in Malignant and Benign Biliary Obstructions
Ahmed Abdel-Razik et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2016)
Intracellular autocrine VEGF signaling promotes EBDC cell proliferation, which can be inhibited by Apatinib
Sui Peng et al.
CANCER LETTERS (2016)
Apatinib inhibits VEGF signaling and promotes apoptosis in intrahepatic cholangiocarcinoma
Hong Peng et al.
ONCOTARGET (2016)
Dual Inhibition of PI3K-AKT-mTOR- and RAF-MEK-ERK-signaling is synergistic in cholangiocarcinoma and reverses acquired resistance to MEK-inhibitors
Florian Ewald et al.
INVESTIGATIONAL NEW DRUGS (2014)
Thymoquinone induces G2/M arrest, inactivates PI3K/Akt and nuclear factor-κB pathways in human cholangiocarcinomas both in vitro and in vivo
Dongsheng Xu et al.
ONCOLOGY REPORTS (2014)
Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
Sumera Rizvi et al.
GASTROENTEROLOGY (2013)
Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer
Sampurna Chatterjee et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Chemotherapy for cholangiocarcinoma: An update
Natalia Ramirez-Merino et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2013)
VEGF is essential for the growth and migration of human hepatocellular carcinoma cells
Lei Zhang et al.
MOLECULAR BIOLOGY REPORTS (2012)
YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo
Shu Tian et al.
CANCER SCIENCE (2011)
Prognostic Value of Cirrhosis for Intrahepatic Cholangiocarcinoma After Surgical Treatment
Ya-yong Li et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2011)
Molecular Targeted Therapy of Biliary Tract Cancer – Results of the First Clinical Studies
Marcus W. Wiedmann et al.
CURRENT DRUG TARGETS (2010)
Cholangiocarcinoma - Thirty-one-year experience with 564 patients at a single institution
Michelle L. DeOliveira et al.
ANNALS OF SURGERY (2007)
The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma
BK Park et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2006)
Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism
E Gaudio et al.
GASTROENTEROLOGY (2006)
Serum concentrations of vascular endothelial growth factor-D in angiosarcoma patients
Y Amo et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
The role of VEGF-A in glomerular development and function
V Eremina et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2004)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Vascular endothelial growth factor induction of the angiogenic phenotype requires Ras activation.
KN Meadows et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Signaling angiogenesis via p42/p44 MAP kinase and hypoxia
E Berra et al.
BIOCHEMICAL PHARMACOLOGY (2000)
分享论文
